Pegg A E, Roberfroid M, von Bahr C, Foote R S, Mitra S, Bresil H, Likhachev A, Montesano R
Proc Natl Acad Sci U S A. 1982 Sep;79(17):5162-5. doi: 10.1073/pnas.79.17.5162.
In in vitro assays using methylated DNAs as substrates, human liver fractions were shown to be able to catalyze the removal of O6-methylguanine. The amount of removal was proportional to the amount of protein added, and the loss of O6-methylguanine occurred with stoichiometric formation of guanine in the DNA and S-methylcysteine in protein. This indicates that human liver contains a protein similar to that previously found in bacteria exposed to alkylating agents. This protein acts as a transmethylase, transferring the intact methyl group from O6-methylguanine in DNA to a cysteine residue on that protein. A similar activity is present in rodent liver, but it was found that human liver was about 10 times more active in carrying out this reaction. In contrast, there was no difference between the human and rat liver extracts in catalyzing the loss of another methylation product, 7-methylguanine, from alkylated DNA. The liver is the organ most likely to be alkylated after exposure to exogenous potential alkylating agents such as dimethylnitrosamine. The present results show that human liver has a significant capacity to repair O6-methylguanine in DNA, which has been implicated as a critical product in carcinogenesis and mutagenesis.
在以甲基化DNA为底物的体外试验中,人肝组分显示能够催化O6-甲基鸟嘌呤的去除。去除量与添加的蛋白量成正比,并且随着DNA中鸟嘌呤和蛋白中S-甲基半胱氨酸的化学计量形成,O6-甲基鸟嘌呤发生损失。这表明人肝中含有一种类似于先前在接触烷化剂的细菌中发现的蛋白。这种蛋白作为一种转甲基酶,将DNA中O6-甲基鸟嘌呤上完整的甲基转移到该蛋白上的一个半胱氨酸残基上。啮齿动物肝脏中也存在类似的活性,但发现人肝在进行该反应时活性约高10倍。相比之下,人肝提取物和大鼠肝提取物在催化烷基化DNA中另一种甲基化产物7-甲基鸟嘌呤的损失方面没有差异。肝脏是接触外源性潜在烷化剂如二甲基亚硝胺后最有可能被烷基化的器官。目前的结果表明,人肝具有修复DNA中O6-甲基鸟嘌呤的显著能力,而O6-甲基鸟嘌呤被认为是致癌和诱变中的关键产物。